List of Tables:

Table 1 Cancer Biomarker Industry Synopsis, 2017 - 2023
Table 2 Global Cancer Biomarker Market Estimates and Forecast, 2017 - 2023, (USD Million)
Table 3 Global Cancer Biomarker Market by Region, 2017 - 2023, (USD Million)
Table 4 Global Cancer Biomarker Market by Type, 2017 - 2023, (USD Million)
Table 5 Global Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 6 Global Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)
Table 7 North America Cancer Biomarker Market by Type, 2017 - 2023, (USD Million)
Table 8 North America Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 9 North America Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)
Table 10 US Cancer Biomarker Market by Type, 2017 - 2023, (USD Million)
Table 11 US Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 12 US Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)
Table 13 Canada Market by Type, 2017 - 2023, (USD Million)
Table 14 Canada Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 15 Canada Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)
Table 16 South America Cancer Biomarker Market by Type, 2017 - 2023, (USD Million)
Table 17 South America Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 18 South America Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)
Table 19 Europe Cancer Biomarker Market by Type, 2017 - 2023, (USD Million)
Table 20 Europe Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 21 Europe Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)
Table 22 Western Europe Cancer Biomarker Market by Type, 2017 - 2023, (USD Million)
Table 23 Western Europe Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 24 Western Europe Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)
Table 25 Eastern Europe Cancer Biomarker Market by Type, 2017 - 2023, (USD Million)
Table 26 Eastern Europe Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 27 Eastern Europe Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)
Table 28 Asia Pacific Cancer Biomarker Market by Type, 2017 - 2023, (USD Million)
Table 29 Asia Pacific Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 30 Asia Pacific Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)
Table 31 Middle East & Africa Cancer Biomarker Market by Type, 2017 - 2023, (USD Million)
Table 32 Middle East & Africa Cancer Biomarker Market by Application, 2017 - 2023, (USD Million)
Table 33 Middle East & Africa Cancer Biomarker Market by End Users, 2017 - 2023, (USD Million)

LIST OF FIGURE

List of Figures:

Figure 1 Research Process
Figure 2 Segmentation for Global Cancer Biomarker Market
Figure 3 Segmentation Market Dynamics for Global Cancer Biomarker Market
Figure 4 Global Cancer Biomarker market Share, by Type 2016
Figure 5 Global Cancer Biomarker market Share, by Application 2016
Figure 6 Global Cancer Biomarker Market Share, by End Users, 2016
Figure 7 Global Cancer Biomarker Market Share, by Region, 2016
Figure 8 North America Cancer Biomarker Market Share, by Country, 2016
Figure 9 Europe Cancer Biomarker Market Share, by Country, 2016
Figure 10 Asia Pacific Cancer Biomarker Market Share, by Country, 2016
Figure 11 Middle East & Africa Cancer Biomarker Market Share, by Country, 2016
Figure 12 Global Cancer Biomarker Market: Company Share Analysis, 2016 (%)
Figure 13 F. Hoffmann-La Roche AG: Key Financials
Figure 14 F. Hoffmann-La Roche AG: Segmental Revenue
Figure 15 F. Hoffmann-La Roche AG: Geographical Revenue
Figure 16 Becton Dickinson: Key Financials
Figure 17 Becton Dickinson: Segmental Revenue
Figure 18 Becton Dickinson: Geographical Revenue
Figure 19 Abbott Laboratories: Key Financials
Figure 20 Abbott Laboratories: Segmental Revenue
Figure 21 Abbott Laboratories: Geographical Revenue
Figure 22 PerkinElmer, Inc.: Key Financials
Figure 23 PerkinElmer, Inc.: Segmental Revenue
Figure 24 PerkinElmer, Inc.: Geographical Revenue
Figure 25 Bristol-Myers Squibb: Key Financials
Figure 26 Bristol-Myers Squibb: Segmental Revenue
Figure 27 Bristol-Myers Squibb: Geographical Revenue
Figure 28 Bio-Rad Laboratories: Key Financials
Figure 29 Bio-Rad Laboratories: Segmental Revenue
Figure 30 Bio-Rad Laboratories: Geographical Revenue
Figure 31 Bio-Rad Laboratories: Key Financials
Figure 33 F. Hoffmann-La Roche AG: Key Financials
Figure 34 F. Hoffmann-La Roche AG: Segmental Revenue
Figure 35 F. Hoffmann-La Roche AG: Geographical Revenue
Figure 36 Becton Dickinson: Key Financials
Figure 37 Becton Dickinson: Segmental Revenue
Figure 38 Becton Dickinson: Geographical Revenue
Figure 39 Abbott Laboratories: Key Financials
Figure 40 Abbott Laboratories: Segmental Revenue
Figure 41 Abbott Laboratories: Geographical Revenue
Figure 42 PerkinElmer, Inc.: Key Financials
Figure 43 PerkinElmer, Inc.: Segmental Revenue
Figure 44 PerkinElmer, Inc.: Geographical Revenue
Figure 45 Bristol-Myers Squibb: Key Financials
Figure 46 Bristol-Myers Squibb: Segmental Revenue
Figure 47 Bristol-Myers Squibb: Geographical Revenue
Figure 48 Bio-Rad Laboratories: Key Financials
Figure 49 Bio-Rad Laboratories: Segmental Revenue
Figure 50 Bio-Rad Laboratories: Geographical Revenue
Figure 51 Eli Lilly and Company: Key Financials
Figure 52 Eli Lilly and Company: Segmental Revenue
Figure 53 Eli Lilly and Company: Geographical Revenue
Figure 54 Merck & Co., Inc.: Key Financials
Figure 55 Merck & Co., Inc.: Segmental Revenue
Figure 56 Merck & Co., Inc.: Geographical Revenue
Figure 57 Pfizer Inc.: Key Financials
Figure 58 Pfizer Inc.: Segmental Revenue
Figure 59 Pfizer Inc.: Geographical Revenue
Figure 60 GlaxoSmithKline plc: Key Financials
Figure 61 GlaxoSmithKline plc: Segmental Revenue
Figure 62 GlaxoSmithKline plc: Geographical Revenue
Figure 63 QIAGEN N.V: Key Financials
Figure 64 QIAGEN N.V: Segmental Revenue
Figure 65 QIAGEN N.V: Geographical Revenue
Figure 66 Novartis AG: Key Financials
Figure 67 Novartis AG: Segmental Revenue
Figure 68 Novartis AG: Geographical Revenue
Figure 69 Thermo Fisher Scientific Inc.: Key Financials
Figure 70 Thermo Fisher Scientific Inc.: Segmental Revenue
Figure 71 Thermo Fisher Scientific Inc.: Geographical Revenue
Figure 72 Illumina Inc.: Key Financials
Figure 73 Illumina Inc.: Segmental Revenue
Figure 74 Illumina Inc.: Geographical Revenue